Cleveland Clinic has named Semih Sen, a healthcare entrepreneur with more than two decades-worth of international healthcare investment and development experience, to its newly created position of Chief Business Development Officer, effective July 1.
In this role, Sen, a native of Turkey, will identify, assess, and realize new business opportunities; create and implement key strategies for market differentiation; develop plans for new growth initiatives, build strategic partnerships and alliances; and drive diversified revenue growth through joint ventures and commercialization of intellectual property.
Sen will also lead Cleveland Clinic Innovations and report directly to Cleveland Clinic CEO and President Tom Mihaljevic, M.D., and collaborate with the executive team in building an entrepreneurial core that benefit Cleveland Clinic and its patients.
With locations in Canada, Abu Dhabi and London – as well as a strategic collaboration in Shanghai that was announced last year – Cleveland Clinic has a strong international presence.
“Partnerships and innovative growth strategies are more important than ever in today’s ever-changing healthcare landscape,” said Dr. Mihaljevic. “By focusing on long-term growth and development, we will further our mission of improving the lives of as many patients as possible.”
Sen has more than 24 years of international experience in executive administration and financing with a focus on healthcare. As founding partner of Biolinka Investment Holding, Sen raised funds for investments in healthcare and life sciences companies that reached global markets with their innovations. He previously led the development of an integrated healthcare network as a Director at Mubadala Investment Company’s Healthcare Unit, which is Cleveland Clinic’s partner for Cleveland Clinic Abu Dhabi.
Sen is married with three children and currently resides in Moreland Hills, Ohio.